There is additional evidence demonstrating that the fluoropyrimidine-mediated increase in TS protein expression is also due to enhanced stability; treatment of human colon cancer HCT-15 cells with 5-FU, or other TS inhibitors, resulted in enhanced TS protein stability. Here, TYMS is linked to malignant colon neoplasm.